Video summary

300 Prosedur HIFU/FUA RS Abdi Waluyo: Solusi Mioma Tanpa Operasi

Main summary

Key takeaways

Science and Nature

Scientific concepts, discoveries, and nature/biomedical phenomena

HIFU/FUA as non-surgical therapy for gynecologic conditions

High-intensity focused ultrasound (HIFU) / focused ultrasound ablation (FUA) is presented as a non-surgical treatment (no incisions), involving minimal/light sedation and targeted energy delivery to diseased tissue. It is described as being used for:

  • Uterine fibroids (myoma)
  • Adenomyosis

Imaging guidance and precision targeting

The procedure relies on imaging to plan and target energy delivery:

  • MRI is required before treatment to:
    • Determine the pattern of the fibroid
    • Assess blood supply
    • Check for lymph node enlargement
    • Clarify size and exact location for energy targeting
  • During treatment, real-time ultrasound imaging is used.
  • The system is described as combining ultrasound + MRI to improve accuracy.
  • Energy targeting uses a “focus point” concept, directing the energy front/back/left/right and adjusting intensity as needed.

Safety mechanisms and biological mechanism of effect

The therapy is described as:

  • Radiation-free: it uses sound waves, not ionizing radiation
  • Precise, due to imaging guidance

The biological outcome described is coagulation necrosis:

  • Focused ultrasound causes tissue damage, leading to shrinking
  • Cavitation effects (rupture-related phenomena) can produce fluid changes
  • Some treated tissue/fluid may exit via the uterine cavity after therapy

Post-treatment discharge phenomenon

After ablation, patients may experience small sterile discharge lasting approximately 2–3 weeks. It is emphasized that this discharge is:

  • Not like typical vaginal discharge
  • Not described as itchy/smelly
  • Linked to tissue breakdown and exit through the uterine cavity

Treatment protocols mentioned

The transcript includes several procedural and preparatory elements:

  • Skin preparation: clean the lower abdominal skin before therapy
  • Patient positioning: prone position (face down), with legs positioned relative to the machine
  • Light sedation:
    • Involves anesthesiology
    • Kept light to allow communication and reduce risk in patients with comorbidities (e.g., hypertension, heart/lung disorders)
  • Pre-procedure diet: liquid diet for 2–3 days beforehand
  • MRI-based planning: used for energy direction and estimating total energy
  • Follow-up schedule: outcomes tracked at 3 months, 6 months, and 12 months

Reproductive outcomes and obstetric implications (as claimed)

The video makes several claims regarding reproductive outcomes and pregnancy safety:

  • High therapeutic success (clinic data referenced)
  • Reduction in fibroid volume on follow-up
  • Spontaneous pregnancies occurred in two cases
  • Conventional approaches: surgical birth is typically recommended
  • With HIFU/FUA, it is claimed that because normal uterine muscle is reportedly not damaged, spontaneous delivery may be possible
  • “World literature” is cited (without specific authors/journals) to claim no pregnancy complications for babies born from treated uteruses (as presented by the speaker)

A potential additional application mentioned:

  • Placental implantation abnormalities: placenta accreta/percreta
  • Concept: ablate the placental area to reduce bleeding risk
  • It is stated (as a comparison point) that removing the uterus is conventional best practice in those cases

Disease behavior and when to intervene

The transcript describes typical disease behavior and diagnostic timing:

  • Myomas/adenomyosis typically shrink after menopause, unless malignant disease is suspected
  • It emphasizes that:
    • Some cases are asymptomatic (claimed 25%)
    • Symptoms can be non-specific, leading to late diagnosis
  • It also claims that untreated fibroids in young women may affect reproductive potential:
    • Young patients with large fibroids may show reduced AMH (Anti-Müllerian Hormone), described as “egg reserve”
    • An example is given where young patient AMH is comparable to an older age (e.g., like ~40)
    • Suggested mechanism: fibroids may “consume” nutrients needed by ovaries, potentially reducing reproductive function

Procedure duration and factors affecting it

Procedure time is described as depending on location, size, and patient tolerance:

  • Fastest: ~45 minutes to 1 hour
  • Longest: up to ~3 hours
  • Learning curve/real-world factors:
    • Inadequate sedation depth or patient movement may require pausing/resting to ensure correct positioning

Researchers or sources featured (as stated)

No individual researchers or specific academic papers are explicitly cited. References include:

  • “World literature” (no specific authors/journals named)
  • CNBC Indonesia (program/source context)

Named person featured

  • Doctor Sigit (Abdi Waluyo Hospital; host/interviewee)

Other named individual

  • Maria Katarina (CNBC Indonesia presenter/interviewer)

Original video